Published: Apr 06, 2021, 03:20 IST | Updated: Apr 06, 2021, 03:20 IST
Indian pharma Cadila Healthcare has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial.